Princeton Biopharma Capital Partners
-
Fidelis Animal Health, Inc. Nov 05, 2024 Ethiqa XR, an extended-release buprenorphine, adds captive rodents and laboratory rabbits to label for 72-hour control of post-procedural pain. NORTH BRUNSWICK, N.J., Nov. 5, 2024 /PRNewswire/ — Fidelis Animal Health, Inc. has received notification from the Food and Drug Administration (FDA) that Ethiqa XR (buprenorphine extended-release injectable suspension) 1.3 mg/mL is now indicated for the control of…
-
Richmond, Virginia, Oct. 01, 2024 (GLOBE NEWSWIRE) — Kaléo, a privately-held U.S. pharmaceutical company has announced a redesign of the AUVI-Q® (epinephrine injection, USP) commercial team structure to increase in-office support for healthcare providers. AUVI-Q is a prescription medicine used to treat emergency allergic reactions, including anaphylaxis, in people who are at risk for or…
-
Jan 24, 2024, 08:00 ET RICHMOND, Va., Jan. 24, 2024 /PRNewswire/ — Kaléo, a privately-held pharmaceutical company, is partnering with Brittany Mahomes, co-owner of the Kansas City Current soccer team and mom of two young children with food allergies, to raise awareness of how to recognize and respond to a life-threatening food allergy reaction in infants and toddlers.*…
-
Posted on August 10, 2023 13 years after launching a business pitch competition for Pitt healthcare technologies, Pitt alum Michael Wells reflects on the growth of the university’s culture of innovation and entrepreneurship Michael Wells had already developed an innovation mindset while earning both a bachelor’s and master’s degree from the University of Pittsburgh School…
-
October 25, 2022 08:00 ET | Source: Kaléo Richmond, Virginia, Oct. 25, 2022 (GLOBE NEWSWIRE) — Kaléo, a fully integrated pharmaceutical company dedicated to inventing, manufacturing, and commercializing life-transforming products, today announced the appointment of Major General Elder Granger, M.D., U.S. Army, (Ret) as an independent member of its Board of Managers. Before retiring from the U.S.…
-
February 06, 2020 9:54am ESTDownload as PDF Transaction to Further Accelerate the Company’s Growth and Expand Distribution Footprint AMSTERDAM, Netherlands and NEW YORK, Feb. 06, 2020 (GLOBE NEWSWIRE) — Funds managed by affiliates of Apollo Global Management, Inc. (together with its consolidated subsidiaries, “Apollo”) (NYSE: APO), a leading global alternative investment manager, today announced that…
-
Sabine Schindlbauer Apr 11, 2019 Following a week of inspiring conversations on impact, entrepreneurship and tech for good at ACTAI Global’s Necker Island event, the stage was set for the Extreme Tech Challenge Finals on Sir Richard Branson’s Necker Island on April 3rd. With contestants participating from all over the world, including Thailand, Australia, and Turkey, this…